Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice

被引：38

作者：

Falini, Brunangelo ^{[1
]}

Martelli, Maria Paola ^{[1
]}

Mecucci, Cristina ^{[1
]}

Liso, Arcangelo ^{[2
]}

Bolli, Niccolo ^{[1
]}

Bigerna, Barbara ^{[1
]}

Pucciarini, Alessandra ^{[1
]}

Pileri, Stefano ^{[3
]}

Meloni, Giovanna ^{[4
]}

Martelli, Massimo F. ^{[1
]}

Haferlach, Torsten ^{[5
]}

Schnittger, Susanne ^{[5
]}

机构：

[1] Univ Perugia, Inst Hematol, Perugia, Italy

[2] Univ Foggia, Inst Hematol, Foggia, Italy

[3] Univ Bologna, Hematopathol Sect, Policlin S Orsola, Bologna, Italy

[4] Univ Roma La Sapienza, Inst Hematol, Rome, Italy

[5] Munich Leukemia Lab GmbH, Munich, Germany

来源：

HAEMATOLOGICA | 2008年 / 93卷 / 05期

关键词：

acute myeloid leukemia; nucleophosmin; NPM; mutations; antibodies; immunohistochemistry;

D O I：

10.3324/haematol.12225

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We investigated the NPM1 mutation status or subcellular expression of NPM protein (nuclear vs. aberrant cytoplasmic) at diagnosis and relapse in 125 patients with acute myeloid leukemia from Italy and Germany. All 52 patients with acute myeloidleukemia carrying at diaggnosis mutated or cytoplasmic NPM (NPMc(+) acute myeloid leukemia) retained this feature at relapse. Notably, cytoplasmic mutated NP has now been retained for eight years in a xenotransplant model of NPMc(+) acute myeloid leukemia in immunodeficient mice. None of 73 acute myeloid leukemia patients carrying at diagnosis wild-type NPM1 gene or showing at immunohistochemistry nucleus-restricted expression of nucleophosmin (NPMc(+) acute myeloid leukemia), which is predictive of NPM1 gene in germline configuration, acquired cytoplasmic mutated NPM at relapse.This finding further confirms that NPMc(+ )acute myeloid leukemia represents a primary event rather than a transformation stage of NPMc(+) acute myeloid leukemia.The stability of cytoplasmic mutated NPM in patients with acute myeloid leukemia, even at relapse in extramedullary sites, and in a xenotransplant model, suggest this event is crucial for leukemogenesis and represents the rationale for monitoring minimal residual disease and molecular targeted therapy in NPMc(+) acute myeloid leukemia.

引用

页码：775 / 779

页数：5

共 25 条

[1] Identification and functional characterization of a cytoplasmic nucleophosmin leukaemic mutant generated by a novel exon-11 NPM1 mutation [J].

Albiero, E. ;

Madeo, D. ;

Bolli, N. ;

Giaretta, I. ;

Di Bona, E. ;

Martelli, M. F. ;

Nicoletti, I. ;

Rodeghiero, F. ;

Falini, B. .

LEUKEMIA, 2007, 21 (05) :1099-1103

[2] Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance [J].

Alcalay, M ;

Tiacci, E ;

Bergomas, R ;

Bigerna, B ;

Venturini, E ;

Minardi, SP ;

Meani, N ;

Diverio, D ;

Bernard, L ;

Tizzoni, L ;

Volorio, S ;

Luzi, L ;

Colombo, E ;

Lo Coco, F ;

Mecucci, C ;

Falini, B ;

Pelicci, PG .

BLOOD, 2005, 106 (03) :899-902

[3] Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia [J].

Bolli, N ;

Galimberti, S ;

Martelli, MP ;

Tabarrini, A ;

Roti, G ;

Mecucci, C ;

Martelli, MF ;

Petrini, M ;

Falini, B .

LANCET ONCOLOGY, 2006, 7 (04) :350-352

[4] Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants [J].

Bolli, Niccolo ;

Nicoletti, Ildo ;

De Marco, M. Felicetta ;

Bigerna, Barbara ;

Pucciarini, Alessandra ;

Mannucci, Roberta ;

Martelli, Maria Paola ;

Liso, Arcangelo ;

Mecucci, Cristina ;

Fabbiano, Francesco ;

Martelli, Massimo F. ;

Henderson, Beric R. ;

Falini, Brunangelo .

CANCER RESEARCH, 2007, 67 (13) :6230-6237

[5] Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations [J].

Chou, W-C ;

Tang, J-L ;

Wu, S-J ;

Tsay, W. ;

Yao, M. ;

Huang, S-Y ;

Huang, K-C ;

Chen, C-Y ;

Huang, C-F ;

Tien, H-F .

LEUKEMIA, 2007, 21 (05) :998-1004

[6] Nucleophosmin mutations in De novo acute myeloid leukemia:: The age-dependent incidences and the stability during disease [J].

Chou, WC ;

Tang, JL ;

Lin, LI ;

Yao, M ;

Tsay, W ;

Chen, CY ;

Wu, SJ ;

Huang, CF ;

Chiou, RJ ;

Tseng, MH ;

Lin, DT ;

Lin, KH ;

Chen, YC ;

Tien, HF .

CANCER RESEARCH, 2006, 66 (06) :3310-3316

[7] Detection of normal and chimeric nucleophosmin in human cells [J].

Cordell, JL ;

Pulford, KAF ;

Bigerna, B ;

Roncador, G ;

Banham, A ;

Colombo, E ;

Pelicci, PG ;

Mason, DY ;

Falini, B .

BLOOD, 1999, 93 (02) :632-642

[8] Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. [J].

Falini, B ;

Mecucci, C ;

Tiacci, E ;

Alcalay, M ;

Rosati, R ;

Pasqualucci, L ;

La Starza, R ;

Diverio, D ;

Colombo, E ;

Santucci, A ;

Bigerna, B ;

Pacini, R ;

Pucciarini, A ;

Liso, A ;

Vignetti, M ;

Fazi, P ;

Meani, N ;

Pettirossi, V ;

Saglio, G ;

Mandelli, F ;

Lo-Coco, F ;

Pelicci, P ;

Martelli, MF .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :254-266

[9] Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif [J].

Falini, B. ;

Albiero, E. ;

Bolli, N. ;

De Marco, M. F. ;

Madeo, D. ;

Martelli, M. ;

Nicoletti, I. ;

Rodeghiero, F. .

LEUKEMIA, 2007, 21 (09) :2052-2054

[10] NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia [J].

Falini, Brunangelo ;

Mecucci, Cristina ;

Saglio, Giuseppe ;

Lo Coco, Francesco ;

Diverio, Daniela ;

Brown, Patrick ;

Pane, Fabrizio ;

Mancini, Marco ;

Martelli, Maria Paola ;

Pileri, Stefano ;

Haferlach, Torsten ;

Haferlach, Claudia ;

Schnittger, Susanne .

HAEMATOLOGICA, 2008, 93 (03) :439-442

← 1 2 3 →